Bad News! AstraZeneca COVID-19 Vaccine Trial pauses after a participant grows ill

New Delhi : Amidst the Coronavirus crisis, America’s AstraZeneca company was soon to deliver good news, but for now, the world has suffered a major setback. AstraZeneca has put an end to its last-stage vaccine trial. AstraZeneca’s vaccine trial has been stopped after a volunteer involved in a human trial fell ill. AstraZeneca issued a statement saying that this is a routine interruption because nothing is yet understood about the illness of the person involved in the trial.

At the same time, according to the report of a health news website, a volunteer participating in the trial has seen serious adverse reactions suspected of the vaccine and in view of this, it has been decided to stop the trial of the last phase of the vaccine.

“Due to the standard review process and to review safety data, vaccination trials have been halted,” Quoting a statement from the spokesperson for AstraZeneca, the report said. The study is testing the COVID-19 vaccine being developed by researchers at AstraZeneca and the University of Oxford in various locations, including the United Kingdom, where an adverse event was reported.

However, a detailed explanation of what the case was and when the adverse reaction to the vaccine was reported could not be known. However, it is being told that the participants who have been given the vaccine for trial will recover.

The trial of the Corona vaccine has affected trials of other AstraZeneca vaccines. It has also affected the clinical trials being carried out by other vaccine manufacturers. Now all of them will also be looking for such a concept so that the proper effect of the vaccine can be understood.

The statement from the spokesperson for AstraZeneca states that ‘In large trials, the disease will be coincidental, but it should be reviewed independently to be carefully examined.’ The State reported that serious adverse reactions vary and may include issues such as hospitalization, dangerous illness, and even death.

However, AstraZeneca has not commented on it so far. Although nine major U.S. and European vaccine developers on Tuesday resolved to maintain the scientific safety and efficacy standards for their experimental vaccines despite the emergency to control the coronavirus epidemic. He said that the vaccine is urgently needed, but we will not compromise on its standards and effectiveness. By all means, we will approve the vaccine only after testing.

The race to manufacture the Corona vaccine also includes Johnson & Johnson, Merck & Company, Moderna Inc., Novavex Inc., Sanofi, Pfizer, GlaxoSmithKline, Bayonet, etc.